SCHEMBL2134640

SCHEMBL2134640

Cc1ccc2nc(NN)oc2c1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 7/20 0.54
KDM4E B2RXH2 6/20 0.54
HSD17B10 Q99714 4/20 0.51
NPC1 O15118 9/20 0.51
RAB9A P51151 9/20 0.51
SMN1; SMN2 Q16637 6/20 0.51
ALDH1A1 P00352 6/20 0.51
HPGD P15428 5/20 0.51
TDP1 Q9NUW8 2/20 0.51
MEN1 O00255 1/20 0.51
KMT2A Q03164 1/20 0.51
FBP1 P09467 1/20 0.49
USP2 O75604 1/20 0.48
MAPK10 P53779 1/20 0.48
TP53 P04637 2/20 0.46
PKM P14618 1/20 0.46
RPS6KA3 P51812 1/20 0.46
LMNA P02545 1/20 0.45
AGTR1 P30556 1/20 0.45
OPRK1 P41145 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8034874 0.79 MAPT (0.56) MAPTKDM4EHSD17B10NPC1RAB9A
SCHEMBL22468097 0.79 MAPT (0.47) MAPTKDM4EHSD17B10NPC1RAB9A
SCHEMBL2135773 0.79 PIK3CG (0.61) MAPTKDM4ENPC1RAB9ASMN1; SMN2
SCHEMBL11261015 0.78 MAPT (0.50) MAPTKDM4EHSD17B10NPC1RAB9A
SCHEMBL33525260 0.78 NPC1 (0.55) MAPTKDM4ENPC1RAB9ASMN1; SMN2
SCHEMBL25788987 0.78 NPC1 (0.55) MAPTKDM4ENPC1RAB9ASMN1; SMN2
SCHEMBL15450923 0.77 PIK3CA (0.51) MAPTKDM4EHSD17B10NPC1RAB9A
SCHEMBL8370275 0.77 NPC1 (0.66) MAPTKDM4EHSD17B10NPC1RAB9A
SCHEMBL15450959 0.77 FBP1 (0.61) MAPTKDM4EHSD17B10NPC1RAB9A
SCHEMBL2544239 0.76 KDM4E (0.48) MAPTKDM4EHSD17B10NPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8242278-B2 Process for producing biaryl compound SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2012-08-14 US disclosed
US-20120101278-A1 PROCESS FOR PRODUCING BIARYL COMPOUND HAGIYA KOJI (JP) 2012-04-26 US disclosed
EP-1473286-B1 PROCESS FOR PRODUCING BIARYL COMPOUND SUMITOMO CHEMICAL CO (JP) 2009-11-04 EP disclosed
US-20090216017-A1 PROCESS FOR PRODUCING BIARYL COMPOUND HAGIYA KOJI 2009-08-27 US disclosed
US-7554000-B2 Process for producing biaryl compound SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2009-06-30 US disclosed
CN-1303043-C Process for producing biaryl compound SUMITOMO CHEMICAL CO (JP) 2007-03-07 CN disclosed
US-20050096471-A1 Process for producing biaryl compound SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2005-05-05 US disclosed
EP-1473286-A1 PROCESS FOR PRODUCING BIARYL COMPOUND Sumitomo Chemical Company, Limited (JP) 2004-11-03 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120101278-A1 PROCESS FOR PRODUCING BIARYL COMPOUND PPOX, CAT, TYR MAPT 3403/4885KDM4E 3428/4885HSD17B10 225/4885
US-20090216017-A1 PROCESS FOR PRODUCING BIARYL COMPOUND PPOX, CAT, TYR MAPT 3403/4885KDM4E 3428/4885HSD17B10 225/4885
US-20050096471-A1 Process for producing biaryl compound PPOX, CAT, TYR MAPT 3403/4885KDM4E 3428/4885HSD17B10 225/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.